{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T05:19:02Z","timestamp":1735708742062,"version":"3.32.0"},"reference-count":0,"publisher":"Sociedade Portuguesa de Reumatologia","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ARP Rheumatol"],"DOI":"10.63032\/dnpz5424","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T11:15:21Z","timestamp":1735643721000},"page":"320-323","source":"Crossref","is-referenced-by-count":0,"title":["The emerging role of Rituximab in the treatment of large granular lymphocytic leukemia associated with rheumatoid arthritis: a single center experience"],"prefix":"10.63032","volume":"3","member":"49459","published-online":{"date-parts":[[2024,12,31]]},"container-title":["ARP Rheumatology"],"original-title":[],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T11:15:30Z","timestamp":1735643730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.arprheumatology.com\/section.php?id=1733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12,31]]}},"URL":"https:\/\/doi.org\/10.63032\/dnpz5424","relation":{},"ISSN":["2795-4552","2795-4552"],"issn-type":[{"value":"2795-4552","type":"print"},{"value":"2795-4552","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,31]]}}}